D
Actinium Pharmaceuticals, Inc. ATNM
$1.71 $0.074.27% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 3.72% 2.02% 21.66% 18.40% 8.02%
Total Depreciation and Amortization 1.37% -2.91% 2.66% 7.18% 4.01%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 152.41% 202.53% 37.74% 28.81% 16.66%
Change in Net Operating Assets -163.90% -176.30% 70.40% 113.25% 652.20%
Cash from Operations 9.63% 16.05% 30.13% 26.90% 19.55%
Capital Expenditure 100.00% 100.00% 92.81% 93.49% 80.66%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 100.00% 100.00% 92.81% 93.49% 80.66%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -28.57% -80.00% -125.00% -100.00% -16.67%
Issuance of Common Stock -84.00% -49.57% 97.20% 64.33% 66.44%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -84.03% -49.59% 97.18% 64.32% 66.46%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -399.20% -72.51% 88.47% 85.26% 79.20%